Results 91 to 100 of about 1,634 (161)

Epidemiological Impact of Nirsevimab on Admissions for Bronchiolitis in a Pediatric Emergency Department: A Single-Center Cohort Study. [PDF]

Viruses
Castagno E, Aschieri C, Ferri I, El Khbazi S, Milani L, Comoretto RI, Raffaldi I, Tardivo I, Spada M, Bondone C, Fagioli F.   +10 more
europepmc   +1 more source

Real-world effectiveness of nirsevimab against RSV hospitalisation in infants during a season with low coverage and delayed circulation in Beijing, China: a population-based retrospective cohort study. [PDF]

Lancet Reg Health West Pac
Li J, Suo L, Wei L, Cao Z, Lu F, Xu H, Luo J, Shen Y, Gao P, Wu D, Feng Z, Yu R, Guo M, Wang Q, Yang P.   +14 more
europepmc   +1 more source

Health care utilization and cost implications of Chile's 2024 nirsevimab strategy for RSV prevention: a counterfactual analysis. [PDF]

Lancet Reg Health Am
Sauré D, Zgheib A, Torres JP, Goic M, Thraves C, Pacheco J, Burgos J, Del Solar F, Neira I, O'Ryan M, Basso LJ.   +10 more
europepmc   +1 more source

Nirsevimab Immunization to Prevent Pediatric RSV Hospitalizations.

JAMA Pediatr
Attaianese F, Carreras G, Trapani S, Alberti I, Aricò M, Attanasi M, Bertolucci G, Bressan S, Caselli D, Casotto V, Cazzato S, Chiarelli F, Felici E, Frusciante A, Galeone MA, Garazzino S, Giannattasio A, Gitto E, Guerriero A, Guida F, Iudica G, Lanari M, Mandato C, Manzini A, Martelli G, Milani GP, Moriondo M, Notarangelo LD, Nunziata F, Pellegrino R, Peroni D, Piccotti E, Ponticiello E, Ricci S, Rulli I, Savoia F, Silvestro E, Sisto A, Soro F, Tonetto S, Zago A, Dani C, Azzari C, Indolfi G.   +43 more
europepmc   +1 more source

Understanding real-world effectiveness of nirsevimab and the characteristics of breakthrough RSV infections: a study protocol of individual-participant-level data meta-analysis (the GEMINI study). [PDF]

BMJ Open Respir Res
Ren S, Zhang H, Deng S, Nair H, Li Y.
europepmc   +1 more source

Broadly neutralizing nanobodies target a defined structural pivot site on the RSV fusion protein. [PDF]

EMBO Mol Med
Wang Q, Ke X, Li E, Hong D, Cheng Z, Li H, Zhang J, Jin T, Gong R, Shu B, Chiu S.   +10 more
europepmc   +1 more source

Knowledge, attitudes, and practices of pediatricians in Crete, Greece, regarding RSV immunization: a cross-sectional study. [PDF]

Eur J Pediatr
Vrentzos D, Pavlopoulou I, Syrogiannopoulos GA, Grivea I, Ladomenou F.   +4 more
europepmc   +1 more source

Comparative Analysis of Reported Adverse Events with Nirsevimab and Palivizumab: A FAERS Observational Study. [PDF]

Kans J Med
Touffaha I, Ablah E, Okut H, Homan G.
europepmc   +1 more source

Nirsevimab and a Community Recall-Based Immunization Strategy for Child Bronchiolitis Prevention.

JAMA Netw Open
Boracchini R, Canova B, Cesarini M, De Marchi I, Brigadoi G, Barbieri E, Donà D, Giaquinto C, Baraldi E, Cantarutti A.   +9 more
europepmc   +1 more source

Meta-analysis of the efficacy of palivizumab versus nirsevimab at preventing medically attended respiratory syncytial virus infections in non-hospitalized preterm infants. [PDF]

Hum Vaccin Immunother
Fullarton J, Paes B, Waghorne N, Keary I, Rodgers-Gray B, Carbonell-Estrany X.   +5 more
europepmc   +1 more source